Otute A.

Otute A. has a strong background in technical operations and manufacturing and development within the pharmaceutical industry. They most recently worked at Neumora as the Vice President of Technical Operations since September 2020. Before that, they held the same position at BlackThorn Therapeutics, which was later acquired by Neumora. At BlackThorn Therapeutics, Otute A. also served as the Head of CMC from January 2018 to June 2019. Prior to BlackThorn Therapeutics, they worked at Relypsa as the Executive Director of Drug Substance Manufacturing and Development and later as the Senior Director of Drug Substance Manufacturing and Development. Otute A. also has experience at Exelixis as the Director and Associate Director of Process Engineering, as well as a Senior Research Scientist. They began their career at Bristol-Myers Squibb Company as a Senior Research Investigator.

Otute A. completed a Bachelor of Science degree in Chemical Engineering from the University of California, Berkeley from 1989 to 1993. Following this, they pursued a Master's degree in Chemical Engineering from Northeastern University between 1993 and 1995. Then, from 1996 to 2000, Otute A. obtained a Ph.D. in Chemical Engineering from the New Jersey Institute of Technology. The education history does not mention any specific degree or field of study from Arizona State University or Vienna International School (VIS).